Characteristics | Non-contacted group n = 450 | Contacted group n = 1062 | Total N = 1512 |
---|---|---|---|
Age in yearsa | |||
16–25 | 104 (25.11) | 240 (22.60) | 344 (22.75) |
26–35 | 129 (28.67) | 267 (25.14) | 396 (26.19) |
36–45 | 97 (21.56) | 260 (24.48) | 357 (23.61) |
46–83 | 120 (26.67) | 295 (27.78) | 415 (27.45) |
Gender (% male)a | 285 (63.33) | 641 (60.36) | 926 (61.24) |
Ethnicity (%)a | |||
White | 7 (1.56) | 37 (3.48) | 44 (2.91) |
Pardo (mixed) | 365 (81.11) | 852 (80.23) | 1217 (80.49) |
Indigenous | 1 (0.22) | 0 (0.00) | 1 (0.07) |
Black | 11 (2.44) | 40 (3.77) | 51 (3.37) |
Yellow | 3 (0.67) | 9 (0.85) | 12 (0.79) |
Unknown | 63 (14.00) | 124 (11.68) | 187 (12.37) |
Type of malariaa | |||
P. Vivax | 444 (98.67) | 1,046 (98.49) | 1490 (98.54) |
P. Falciparum | 5 (1.11) | 8 (0.75) | 13 (0.96) |
Mixed infection/other | 1 (0.22) | 8 (0.75) | 9 (0.60) |
Treatment regimena | |||
Long standard regimen CQ + PQb | 19 (4.22) | 23 (2.17) | 42 (2.78) |
Short standard regimen QC + PQc | 425 (94.44) | 1025 (96.52) | 1450 (95.90) |
Combined therapy AT + PQd | 5 (1.11) | 7 (0.66) | 12 (0.79) |
Mixed malaria schemef | 1 (0.22) | 7 (0.66) | 8 (0.53) |